Change should be part of our daily life. Genpharm has been always centred around being an agile and dynamic organization
In Conversation
Mediclinic is a relatively young brand but we have achieved "super brand" status in four out of the last five years
In this region of the world we have a particular potential to help diabetes and oncology patients
Mundipharma operates in a unique way because while it is a multinational company, it operates under the notion of independent associated companies, meaning that each legal…
Janssen's vision for the GCC is to make a greater impact on the healthcare systems by bringing new and innovative medicines to patients
The entire region holds significant potential as well as numerous opportunities, and Bayer is committed to bringing its products here, accelerating momentum and continue serving our…
I appreciate all the efforts the [UAE] authorities have been putting into fast-tracking registration for innovative products immediately post FDA or EMA approval
We have to adapt by taking conservative steps and understanding that there are certain external factors that come with the territory [in the Middle East &…
Healthcare is a top priority for the UAE. Ensuring quality care for its population is a key deliverable the government is working towards
We have two parallel objectives: improve patient access to medicines and foster economic growth in the region.
Dubai is by far still the hub for the pharmaceutical industry within MEA, and I believe this will continue for many years to come
This is part of our innovation story, which is to provide the right medication to the right patients at the right time.
